Financials
- Market Capitalization 3.55 B
- Employee 10 K
- Founded N/A
- CEO N/A
- Website www.organon.com
- Headquarter New Jersey, United States
- FIGI BBG00ZQRGW24
- Industry Case Farmaceutiche - Generali
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
9.96
Rapporto prezzo/fatturato
0.3
Dividendi per azione
0.34
Rendimento da dividendi %
4.74
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1315 | ORKA Oruka Therapeutics, Inc. - Common Stock | 87.07 USD | +2.97% | -0.26% | +24.87% | +171.50% | 5.25 B USD | ||
| 1393 | MANE Veradermics, Incorporated Common Stock | 114.84 USD | +4.40% | -3.41% | +18.49% | +248.00% | 4.80 B USD | ||
| 1822 | MBX MBX Biosciences, Inc. - Common Stock | 55.00 USD | -8.39% | -4.31% | +53.63% | +291.18% | 2.62 B USD | ||
| 1951 | PVLA Palvella Therapeutics, Inc. - Common Stock | 147.44 USD | +0.97% | +2.29% | +31.54% | +99.65% | 2.11 B USD |